Please see the following two emails responding to this HHS announcement...
Email# 1
----- Forwarded Message -----
From: CARL TUTTLE <runagain@comcast.net>
To: TheDanaParish@gmail.com <thedanaparish@gmail.com>
Cc: jayanta.bhattacharya@nih.gov <jayanta.bhattacharya@nih.gov>; kalachakra108@aol.com <kalachakra108@aol.com>; sephillips18@gmail.com <sephillips18@gmail.com>; sherman.packard@gc.nh.gov <sherman.packard@gc.nh.gov>; Stephanie.Haridopolos@hhs.gov <stephanie.haridopolos@hhs.gov>; Sharon.Carson@gc.nh.gov <sharon.carson@gc.nh.gov>; Jason@Osborne4NH.com <jason@osborne4nh.com>
Sent: Sunday, May 31, 2026 at 09:21:29 AM EDT
Subject: HHS Unveils Sweeping Plan to Combat Lyme Disease and Advance Treatment
HHS Unveils Sweeping Plan to Combat Lyme Disease and Advance Treatment
Dana Parish 5min speech from the NH State Capitol with U.S. Department of Health and Human Services on behalf of Bay Area Lyme Foundation:
https://www.facebook.com/reel/1024001896731555
Dear Dana,
Thank you for that extremely accurate speech on May 29th!
IACCI or Infection-associated Chronic Conditions and Illnesses replaced Post Treatment Lyme Disease Syndrome (PTLDS) when that acronym wasn’t good enough. IACCI is yet another distraction to take away from the fact that we have been dealing with an antibiotic resistant/tolerant superbug that never had the correct treatment in the first place. Those who controlled the narrative when PTLDS was invented were also in control under the new acronym. Chronic Lyme still does not exist no matter what acronym you use and this is why Dr. Horowitz attempt to obtain NIH funding for his Dapsone research was recently denied. Reason given: “Chronic Lyme does not exist” Dapsone by the way cured his wife’s chronic Lyme.
A cure for chronic Lyme would give the public an excuse not to take their precious Lyme vaccine just like ivermectin was not allowed to be prescribed for Covid because that too threatened vaccine uptake.
There are controlling factors within the NIH that need to go if we are to find a cure for chronic Lyme. i.e. Adriana Marques and Co.
I’m not overly excited about the HHS announcement until we see these roadblocks eliminated because these individuals rejecting Horowitz’s research will undermine any attempt to find a cure. It was that rush to create a vaccine early in the discovery stage of the disease that led to the deliberate mishandling.
For example…
It was once believed that rifampin was curative in treating Brucellosis but when symptoms returned doxycycline was added to the mix and when that too failed a third antibiotic, streptomycin was added to the current treatment regimen. [1] [2]
In 1985 the worldwide incidence of leprosy was 6,000,000. Last year, it was 800,000. The only thing that changed was the addition of rifampin to dapsone in the treatment of the disease. Rifampin was added to dapsone because the M leprae were becoming resistant and it was a new antibiotic at that time.
Treatments for multidrug-resistant tuberculosis have been introduced (bedaquiline and delamanid) with more in the pipeline. [3]
A new treatment for recurrent Clostridium difficile was recently studied (bezlotoxumab) for reducing the risk of a repeat infection. [4]
In contrast, oral amoxicillin or doxycycline remains the treatment of choice for treating Lyme disease for over thirty years regardless if debilitating symptoms return. Dr. Allen Steere knew that these antibiotics were not effective for all patients [5] (see 1977 attachment) but there has been no change in treatment or research to find more effective ways to eradicate the infection in all stages of disease.
At what point in time do we recognize that we are dealing with an antibiotic resistant/tolerant superbug and focus our research on finding new antimicrobials for this life-altering/life-threatening disease? Steere and his thirty-year bias against persistent infection are toxic to the advancement of science as more of the population becomes severely disabled from persistent Lyme disease.
The focus has been to discredit the sick and disabled along with the clinicians attempting to help these people as we observed in the Lancet article in which Steere coauthored:
Antiscience and ethical concerns associated with advocacy of Lyme disease
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(11)70034-2/abstract?rss=yes
For over three decades now Lyme has been portrayed as easily diagnosed and treated with a one-size-fits-all IDSA antibiotic treatment guideline of two to three weeks; basically, a simple nuisance disease like strep throat. Patients who complain of debilitating symptoms after treatment are somehow delusional and clinicians who treat those returning symptoms beyond the IDSA guideline must be dishonest as described in the Lancet article.
The advancement in the treatment of Lyme disease will come from researchers who recognize that the groupthink mentality spearheaded by Steere and his colleagues is the most shameful affair in the history of medicine.
Please forward to your HHS contacts
Respectfully Submitted
Carl Tuttle
Independent Researcher
Hudson, New Hampshire
Member of NH Governor Chris Sununu’s HB490 Commission to Study Lyme Disease
https://legiscan.com/NH/text/HB490/id/1962817
Cc: Dr. Jay Bhattacharya, Director of the National Institutes of Health
REFERENCES (Please read!)
[1] Chronic Brucellosis and Persistence of Brucella melitensis DNA
After acute brucellosis infection, symptoms persist in a minority of patients for more than 1 year. Such patients are defined as having chronic brucellosis. Since no objective laboratory methods exist to confirm the presence of chronic disease, these patients suffer delays in both diagnosis and treatment.
[2] Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
https://www.ncbi.nlm.nih.gov/pubmed/25246401
The doxycycline-streptomycin-rifampin regimen eliminates Brucella DNA more efficiently than doxycycline-streptomycin, which may result in superior long-term clearance of Brucella.
[3] Global Introduction of New Multidrug-Resistant Tuberculosis Drugs—Balancing Regulation with Urgent Patient Needs
https://wwwnc.cdc.gov/eid/article/22/3/15-1228_article
[4] New C.diff treatment reduces recurrent infections by 40%
https://www.sciencedaily.com/releases/2017/01/170126081724.htm
[5] Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.
https://pubmed.ncbi.nlm.nih.gov/836338/
Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM.
Excerpt:
"The best treatment for this illness is not clear. Some physicians have reported that penicillin or tetracycline results in disappearance of the skin lesion (41,42), but others find antibiotics ineffective. Four of the patients with expanding skin lesions received penicillin but still developed arthritis."
Email# 2
----- Forwarded Message -----
From: CARL TUTTLE <runagain@comcast.net>
To: TheDanaParish@gmail.com <thedanaparish@gmail.com>
Cc: jayanta.bhattacharya@nih.gov <jayanta.bhattacharya@nih.gov>; kalachakra108@aol.com <kalachakra108@aol.com>; sephillips18@gmail.com <sephillips18@gmail.com>; sherman.packard@gc.nh.gov <sherman.packard@gc.nh.gov>; Stephanie.Haridopolos@hhs.gov <stephanie.haridopolos@hhs.gov>; Sharon.Carson@gc.nh.gov <sharon.carson@gc.nh.gov>; Jason@Osborne4NH.com <jason@osborne4nh.com>
Sent: Monday, June 1, 2026 at 08:48:10 PM EDT
Subject: Re: HHS Unveils Sweeping Plan to Combat Lyme Disease and Advance Treatment
To All:
Please see the following letter addressed to Dr. Raymond Dattwyler who owns 24 patents for Lyme disease that include diagnostic testing and vaccines both live bacteria and oral.
---------- Original Message ----------
From: CARL TUTTLE <runagain@comcast.net>
To: "Raymond_Dattwyler@nymc.edu" <Raymond_Dattwyler@nymc.edu>
Cc: "npjvaccines@nature.com" <npjvaccines@nature.com>, "abarrett@utmb.edu" <abarrett@utmb.edu>, "R.W.Titball@exeter.ac.uk" <R.W.Titball@exeter.ac.uk>, "mgomesso@uthsc.edu" <mgomesso@uthsc.edu>
Date: 01/06/2023 2:46 PM
Subject: The year that shaped the outcome of the OspA vaccine for human Lyme disease
npj Vaccines Jan 2022
The year that shaped the outcome of the OspA vaccine for human Lyme disease
https://www.nature.com/articles/s41541-022-00429-5
Raymond J. Dattwyler & Maria Gomes-Solecki
Department of Microbiology and Immunology
New York Medical College
Valhalla, NY
Raymond J. Dattwyler, Corresponding Author
Dear Dr. Dattwyler,
I read your manuscript with great interest as you call attention to a treatment-resistant Lyme arthritis with “no evidence of DNA” found in the joints of patients after antibiotic treatment.
For some strange reason however, I could not find the following 1995 publication within your paper identifying treatment-resistant neuroborreliosis:
European Neurology 1995
Seronegative Chronic Relapsing Neuroborreliosis
https://www.karger.com/Article/Abstract/117104
Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d
Abstract
We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.
In fact, Dr. Dattwyler there seems to be a great deal of “treatment-resistant” evidence published in multiple journals over the past three decades:
Peer Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases (700 References)
https://www.dropbox.com/s/n09sk90eo6xz7ua/700%20articles%20LYME%20EvidenceofPersistence-V2.pdf?dl=0
So that brings me to the reason for this email...
Question:
Does a chronic relapsing seronegative disease fit the vaccine model? If not, would that, in and of itself, be the hidden reason for denying chronic (treatment-resistant) Lyme disease for almost three decades? In other words, patent royalties and pharmaceutical profits over lifesaving care?
A response to this inquiry is requested.
Carl Tuttle
Hudson, NH
Cc: Alan D.T. Barrett, PhD Editor-in-Chief
Rick Titball, PhD, DSc, Deputy Editor
Carl Tuttle's Letter to the Editor of the BMJ published June 2020
https://www.bmj.com/content/369/bmj.m1041/rr-1
____________________________________________
End of email to Dattwyler
To all on this email thread....
Questions to Google’s Gemini AI:
1. Does a chronic relapsing seronegative disease fit the vaccine model?
AI Response:
A chronic, relapsing, seronegative disease does not fit the traditional vaccine model, which is primarily designed to prevent initial infections. The characteristics you describe present significant scientific and commercial challenges for vaccine developers.
2. Since you agreed that a chronic, relapsing, seronegative disease does not fit the traditional vaccine model this in and of itself would be the motivation to conceal any and all evidence of persistent infection wouldn't you agree? This so-called debate is not a debate at all and deserves a criminal investigation. Who would be a suitable candidate to approach for a legal case?
AI Response:
Allegations of medical fraud are typically handled as civil matters, but they can become criminal if there is evidence of gross negligence, recklessness, or intent to deceive, especially for financial gain.
Carl Tuttle's comment: Suppressing evidence of antibiotic resistance is not collaboration, it is collusion.
The US Centers for Disease Control together with the Infectious Diseases Society of America have propagated a false public health narrative; “Chronic Lyme does not exist.”
What has been deceitfully established here in the US is wreaking havoc globally 1, 2 leaving hundreds of thousands if not millions worldwide in a debilitated state.
References:
1. Lyme disease: Australians 'being treated worse than a dog riddled with mange', Senator John Madigan says
https://www.abc.net.au/news/2016-01-11/lyme-disease-treatment-in-australia-criticised-by-john-madigan/7080708
2. Lyme Disease: French Association Launches Alert Against "A Bacterial AIDS"
https://fr.sputniknews.com/france/201904101040691211-maladie-lyme-association-france-droit-de-guerir-sida-matthias-lacoste/?fbclid=IwAR028YoR08pF5GkEImwiZP9JpxxVG9EURUYjsylDXgeskWk8ft4j-Us0NXE
Lyme activists dumping a red liquid on the walls of the French Blood Establishment in Paris. This is similar to the Act Up AIDS crisis campaign in the early 90’s employed to “Wake the World Up”
Early 90’s AIDS campaign: https://www.theguardian.com/film/2018/apr/06/giant-condoms-and-buckets-of-fake-blood-the-true-story-of-aids-activists-act-up
Carl Tuttle